| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | procollagen glucosyltransferase activity | 5.23e-05 | 3 | 84 | 2 | GO:0033823 | |
| GeneOntologyMolecularFunction | procollagen-lysine 5-dioxygenase activity | 5.23e-05 | 3 | 84 | 2 | GO:0008475 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 5.60e-05 | 18 | 84 | 3 | GO:0022851 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 5.60e-05 | 18 | 84 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 6.63e-05 | 19 | 84 | 3 | GO:0004890 | |
| GeneOntologyMolecularFunction | peptidyl-lysine 5-dioxygenase activity | 1.04e-04 | 4 | 84 | 2 | GO:0070815 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 1.04e-04 | 22 | 84 | 3 | GO:0016917 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.41e-04 | 118 | 84 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | 2'-5'-oligoadenylate synthetase activity | 1.73e-04 | 5 | 84 | 2 | GO:0001730 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.18e-04 | 28 | 84 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 2.40e-04 | 207 | 84 | 6 | GO:0008236 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 2.72e-04 | 212 | 84 | 6 | GO:0017171 | |
| GeneOntologyMolecularFunction | steroid hormone binding | 3.62e-04 | 7 | 84 | 2 | GO:1990239 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 5.03e-04 | 37 | 84 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | P-type sodium transporter activity | 7.70e-04 | 10 | 84 | 2 | GO:0008554 | |
| GeneOntologyMolecularFunction | P-type sodium:potassium-exchanging transporter activity | 7.70e-04 | 10 | 84 | 2 | GO:0005391 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 7.77e-04 | 171 | 84 | 5 | GO:0015103 | |
| GeneOntologyMolecularFunction | benzodiazepine receptor activity | 9.38e-04 | 11 | 84 | 2 | GO:0008503 | |
| GeneOntologyMolecularFunction | P-type potassium transmembrane transporter activity | 9.38e-04 | 11 | 84 | 2 | GO:0008556 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 1.10e-03 | 614 | 84 | 9 | GO:0140657 | |
| GeneOntologyMolecularFunction | dipeptidyl-peptidase activity | 1.12e-03 | 12 | 84 | 2 | GO:0008239 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 1.22e-03 | 50 | 84 | 3 | GO:0099095 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 1.24e-03 | 190 | 84 | 5 | GO:0004252 | |
| GeneOntologyMolecularFunction | peptidase activity | 1.70e-03 | 654 | 84 | 9 | GO:0008233 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 2.23e-03 | 430 | 84 | 7 | GO:0004175 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 2.57e-03 | 441 | 84 | 7 | GO:0016887 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 2.60e-03 | 65 | 84 | 3 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 2.60e-03 | 65 | 84 | 3 | GO:0022824 | |
| GeneOntologyMolecularFunction | L-ascorbic acid binding | 3.16e-03 | 20 | 84 | 2 | GO:0031418 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 3.21e-03 | 70 | 84 | 3 | GO:0003777 | |
| GeneOntologyMolecularFunction | glucosyltransferase activity | 3.82e-03 | 22 | 84 | 2 | GO:0046527 | |
| GeneOntologyMolecularFunction | ankyrin binding | 4.18e-03 | 23 | 84 | 2 | GO:0030506 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 4.20e-03 | 77 | 84 | 3 | GO:0005230 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 4.54e-03 | 24 | 84 | 2 | GO:0099507 | |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid signaling pathway | 1.22e-05 | 35 | 84 | 4 | GO:0007214 | |
| GeneOntologyBiologicalProcess | hydroxylysine biosynthetic process | 1.64e-05 | 2 | 84 | 2 | GO:0046947 | |
| GeneOntologyBiologicalProcess | hydroxylysine metabolic process | 1.64e-05 | 2 | 84 | 2 | GO:0046946 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte migration | 1.09e-04 | 267 | 84 | 7 | GO:0002685 | |
| GeneOntologyBiologicalProcess | viral process | 1.13e-04 | 464 | 84 | 9 | GO:0016032 | |
| GeneOntologyCellularComponent | microvillus | 1.03e-05 | 123 | 84 | 6 | GO:0005902 | |
| GeneOntologyCellularComponent | GABA-A receptor complex | 5.79e-05 | 19 | 84 | 3 | GO:1902711 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | STIM1 SPTBN4 DNAH3 DCDC2C DPP9 AVIL MYO1F MYO1B TUBGCP2 DNAH7 KRT36 DYNC1H1 CNP | 5.83e-05 | 899 | 84 | 13 | GO:0099513 |
| GeneOntologyCellularComponent | GABA receptor complex | 7.90e-05 | 21 | 84 | 3 | GO:1902710 | |
| GeneOntologyCellularComponent | photoreceptor inner segment membrane | 9.52e-05 | 4 | 84 | 2 | GO:0060342 | |
| GeneOntologyCellularComponent | cell cortex | 1.23e-04 | 371 | 84 | 8 | GO:0005938 | |
| GeneOntologyCellularComponent | actin-based cell projection | 1.29e-04 | 278 | 84 | 7 | GO:0098858 | |
| GeneOntologyCellularComponent | cell surface | SELE SEMA6C DPP4 DUOX1 ANOS1 TJP1 CD226 CORIN ROS1 CUBN ATP1A3 MDGA1 HYAL2 | 4.68e-04 | 1111 | 84 | 13 | GO:0009986 |
| GeneOntologyCellularComponent | intercellular canaliculus | 5.64e-04 | 9 | 84 | 2 | GO:0046581 | |
| GeneOntologyCellularComponent | membrane raft | 6.36e-04 | 362 | 84 | 7 | GO:0045121 | |
| GeneOntologyCellularComponent | membrane microdomain | 6.57e-04 | 364 | 84 | 7 | GO:0098857 | |
| GeneOntologyCellularComponent | neuronal cell body membrane | 6.88e-04 | 43 | 84 | 3 | GO:0032809 | |
| GeneOntologyCellularComponent | inner dynein arm | 7.03e-04 | 10 | 84 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | supramolecular fiber | STIM1 SPTBN4 DNAH3 DCDC2C DPP9 AVIL MYO1F MYO1B TUBGCP2 DNAH7 KRT36 DYNC1H1 CNP | 8.16e-04 | 1179 | 84 | 13 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | STIM1 SPTBN4 DNAH3 DCDC2C DPP9 AVIL MYO1F MYO1B TUBGCP2 DNAH7 KRT36 DYNC1H1 CNP | 8.69e-04 | 1187 | 84 | 13 | GO:0099081 |
| GeneOntologyCellularComponent | cell body membrane | 8.93e-04 | 47 | 84 | 3 | GO:0044298 | |
| GeneOntologyCellularComponent | cell leading edge | 8.99e-04 | 500 | 84 | 8 | GO:0031252 | |
| GeneOntologyCellularComponent | sodium:potassium-exchanging ATPase complex | 1.03e-03 | 12 | 84 | 2 | GO:0005890 | |
| GeneOntologyCellularComponent | trans-Golgi network membrane | 1.08e-03 | 112 | 84 | 4 | GO:0032588 | |
| GeneOntologyCellularComponent | dynein complex | 1.34e-03 | 54 | 84 | 3 | GO:0030286 | |
| GeneOntologyCellularComponent | microtubule | 1.35e-03 | 533 | 84 | 8 | GO:0005874 | |
| GeneOntologyCellularComponent | dendrite membrane | 1.49e-03 | 56 | 84 | 3 | GO:0032590 | |
| GeneOntologyCellularComponent | chloride channel complex | 1.57e-03 | 57 | 84 | 3 | GO:0034707 | |
| GeneOntologyCellularComponent | PML body | 1.63e-03 | 125 | 84 | 4 | GO:0016605 | |
| GeneOntologyCellularComponent | rough endoplasmic reticulum | 2.19e-03 | 64 | 84 | 3 | GO:0005791 | |
| GeneOntologyCellularComponent | intercalated disc | 2.60e-03 | 68 | 84 | 3 | GO:0014704 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 2.73e-03 | 238 | 84 | 5 | GO:0097729 | |
| GeneOntologyCellularComponent | actin filament | 2.86e-03 | 146 | 84 | 4 | GO:0005884 | |
| GeneOntologyCellularComponent | axon | STIM1 SPTBN4 AVIL ADGRL1 DIXDC1 ATP1A1 ATP1A3 MDGA1 DYNC1H1 SLC38A8 | 2.99e-03 | 891 | 84 | 10 | GO:0030424 |
| GeneOntologyCellularComponent | GABA-ergic synapse | 4.33e-03 | 164 | 84 | 4 | GO:0098982 | |
| GeneOntologyCellularComponent | neuron projection membrane | 4.41e-03 | 82 | 84 | 3 | GO:0032589 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 4.51e-03 | 25 | 84 | 2 | GO:0005858 | |
| GeneOntologyCellularComponent | apicolateral plasma membrane | 5.64e-03 | 28 | 84 | 2 | GO:0016327 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.97e-05 | 14 | 83 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.97e-05 | 14 | 83 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.97e-05 | 14 | 83 | 3 | IPR013602 | |
| Domain | DHC_N2 | 2.97e-05 | 14 | 83 | 3 | PF08393 | |
| Domain | MT | 2.97e-05 | 14 | 83 | 3 | PF12777 | |
| Domain | AAA_8 | 2.97e-05 | 14 | 83 | 3 | PF12780 | |
| Domain | DHC_fam | 3.70e-05 | 15 | 83 | 3 | IPR026983 | |
| Domain | Dynein_heavy_dom | 3.70e-05 | 15 | 83 | 3 | IPR004273 | |
| Domain | Dynein_heavy | 3.70e-05 | 15 | 83 | 3 | PF03028 | |
| Domain | LYS_HYDROXYLASE | 5.84e-05 | 3 | 83 | 2 | PS01325 | |
| Domain | Procol_lys_dOase | 5.84e-05 | 3 | 83 | 2 | IPR001006 | |
| Domain | OAS1_C | 1.16e-04 | 4 | 83 | 2 | PF10421 | |
| Domain | - | 1.16e-04 | 4 | 83 | 2 | 1.10.1410.20 | |
| Domain | 25A_SYNTH_1 | 1.16e-04 | 4 | 83 | 2 | PS00832 | |
| Domain | 25A_SYNTH_2 | 1.16e-04 | 4 | 83 | 2 | PS00833 | |
| Domain | 2-5-oligoadenylate_synth_CS | 1.16e-04 | 4 | 83 | 2 | IPR006117 | |
| Domain | 25A_SYNTH_3 | 1.16e-04 | 4 | 83 | 2 | PS50152 | |
| Domain | 2-5-oligoAdlate_synth_1_dom2/C | 1.16e-04 | 4 | 83 | 2 | IPR018952 | |
| Domain | 2-5A_synthase | 1.16e-04 | 4 | 83 | 2 | IPR026774 | |
| Domain | GABAA/Glycine_rcpt | 1.41e-04 | 23 | 83 | 3 | IPR006028 | |
| Domain | 2-5-oligoadenylate_synth_N | 1.93e-04 | 5 | 83 | 2 | IPR006116 | |
| Domain | - | 2.89e-04 | 6 | 83 | 2 | 2.140.10.30 | |
| Domain | DPPIV_N | 2.89e-04 | 6 | 83 | 2 | PF00930 | |
| Domain | P-type_ATPase_IIC | 2.89e-04 | 6 | 83 | 2 | IPR005775 | |
| Domain | GABAAa_rcpt | 2.89e-04 | 6 | 83 | 2 | IPR001390 | |
| Domain | Peptidase_S9B_N | 2.89e-04 | 6 | 83 | 2 | IPR002469 | |
| Domain | Myosin_TH1 | 4.04e-04 | 7 | 83 | 2 | PF06017 | |
| Domain | Myosin_TH1 | 4.04e-04 | 7 | 83 | 2 | IPR010926 | |
| Domain | TH1 | 4.04e-04 | 7 | 83 | 2 | PS51757 | |
| Domain | Peptidase_S9 | 1.05e-03 | 11 | 83 | 2 | PF00326 | |
| Domain | Peptidase_S9 | 1.05e-03 | 11 | 83 | 2 | IPR001375 | |
| Domain | Neurotransmitter_ion_chnl_CS | 1.05e-03 | 45 | 83 | 3 | IPR018000 | |
| Domain | Neur_chan_memb | 1.12e-03 | 46 | 83 | 3 | PF02932 | |
| Domain | Neur_chan_LBD | 1.19e-03 | 47 | 83 | 3 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 1.19e-03 | 47 | 83 | 3 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 1.19e-03 | 47 | 83 | 3 | IPR006029 | |
| Domain | - | 1.19e-03 | 47 | 83 | 3 | 2.70.170.10 | |
| Domain | Neur_channel | 1.19e-03 | 47 | 83 | 3 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 1.19e-03 | 47 | 83 | 3 | IPR006202 | |
| Domain | ATPase_dyneun-rel_AAA | 1.72e-03 | 14 | 83 | 2 | IPR011704 | |
| Domain | AAA_5 | 1.72e-03 | 14 | 83 | 2 | PF07728 | |
| Domain | - | 2.25e-03 | 16 | 83 | 2 | 1.20.1110.10 | |
| Domain | P4Hc | 2.25e-03 | 16 | 83 | 2 | SM00702 | |
| Domain | Pro_4_hyd_alph | 2.25e-03 | 16 | 83 | 2 | IPR006620 | |
| Domain | ATPase_P-typ_TM_dom | 2.25e-03 | 16 | 83 | 2 | IPR023298 | |
| Domain | ATPase_P-typ_cation-transptr_C | 2.54e-03 | 17 | 83 | 2 | IPR006068 | |
| Domain | Cation_ATPase_C | 2.54e-03 | 17 | 83 | 2 | PF00689 | |
| Domain | Cation_ATPase_N | 2.85e-03 | 18 | 83 | 2 | PF00690 | |
| Domain | Cation_ATPase_N | 2.85e-03 | 18 | 83 | 2 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 3.18e-03 | 19 | 83 | 2 | IPR004014 | |
| Domain | 2OG-FeII_Oxy | 3.18e-03 | 19 | 83 | 2 | PF03171 | |
| Domain | MAGE_N | 3.52e-03 | 20 | 83 | 2 | SM01392 | |
| Domain | FE2OG_OXY | 3.88e-03 | 21 | 83 | 2 | PS51471 | |
| Domain | AAA+_ATPase | 3.89e-03 | 144 | 83 | 4 | IPR003593 | |
| Domain | AAA | 3.89e-03 | 144 | 83 | 4 | SM00382 | |
| Domain | MAGE_N | 4.25e-03 | 22 | 83 | 2 | PF12440 | |
| Domain | MAGE_N | 4.25e-03 | 22 | 83 | 2 | IPR021072 | |
| Domain | P-loop_NTPase | 4.28e-03 | 848 | 83 | 10 | IPR027417 | |
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 21831918 | ||
| Pubmed | 2.29e-06 | 11 | 85 | 3 | 24348274 | ||
| Pubmed | Retinal pigment epithelial integrity is compromised in the developing albino mouse retina. | 3.05e-06 | 12 | 85 | 3 | 27097562 | |
| Pubmed | 5.03e-06 | 14 | 85 | 3 | 9373155 | ||
| Pubmed | DPP4 TJP1 OTUD4 OAS3 MYO1B ROS1 CHD4 C5 ATP1A1 SEC63 PLOD2 DYNC1H1 CNP MTFMT | 5.68e-06 | 1371 | 85 | 14 | 36244648 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 25516437 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 11378843 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 22815813 | ||
| Pubmed | Serum E-selectin and erythrocyte membrane Na+K+ ATPase levels in patients with rheumatoid arthritis. | 5.90e-06 | 2 | 85 | 2 | 15515123 | |
| Pubmed | All human Na(+)-K(+)-ATPase alpha-subunit isoforms have a similar affinity for cardiac glycosides. | 5.90e-06 | 2 | 85 | 2 | 11546672 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 24391932 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 38060449 | ||
| Pubmed | Na+/K+ ATPase α1 and α3 isoforms are differentially expressed in α- and γ-motoneurons. | 5.90e-06 | 2 | 85 | 2 | 23761886 | |
| Pubmed | The family of human Na+,K+-ATPase genes. A partial nucleotide sequence related to the alpha-subunit. | 5.90e-06 | 2 | 85 | 2 | 3030810 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 23169495 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 22001206 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 30557881 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 21498719 | ||
| Pubmed | Plasma levels of DPP4 activity and sDPP4 are dissociated from inflammation in mice and humans. | 5.90e-06 | 2 | 85 | 2 | 32724076 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 11334715 | ||
| Pubmed | Pathogenic mechanisms in varicose vein disease: the role of hypoxia and inflammation. | 5.90e-06 | 2 | 85 | 2 | 20632821 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | 9.05e-06 | 420 | 85 | 8 | 28065597 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | CDK9 PLOD3 UTP15 TJP1 OASL AP1M1 OAS3 MYO1B TUBGCP2 SEC63 DYNC1H1 CNP CEP55 | 1.11e-05 | 1257 | 85 | 13 | 36526897 |
| Pubmed | 1.12e-05 | 18 | 85 | 3 | 19078961 | ||
| Pubmed | 1.12e-05 | 18 | 85 | 3 | 32496646 | ||
| Pubmed | Anterograde trafficking signals in GABAA subunits are required for functional expression. | 1.77e-05 | 3 | 85 | 2 | 31610743 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 2822726 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 36076959 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 15866709 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 29693275 | ||
| Pubmed | Identification of a VxP Targeting Signal in the Flagellar Na+ /K+ -ATPase. | 1.77e-05 | 3 | 85 | 2 | 26373354 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 27081042 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 17947306 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 10429951 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 11896059 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 11956192 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 28465228 | ||
| Pubmed | Lysyl hydroxylase 3 is a multifunctional protein possessing collagen glucosyltransferase activity. | 1.77e-05 | 3 | 85 | 2 | 10934207 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 9582318 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 18044013 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 26988030 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 16996725 | ||
| Pubmed | An αII Spectrin-Based Cytoskeleton Protects Large-Diameter Myelinated Axons from Degeneration. | 1.77e-05 | 3 | 85 | 2 | 29038243 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 16704418 | ||
| Pubmed | The genes encoding mouse lysyl hydroxylase isoforms map to chromosomes 4,5, and 9. | 1.77e-05 | 3 | 85 | 2 | 11130984 | |
| Pubmed | Na+/K+-ATPase α isoform deficiency results in distinct spreading depolarization phenotypes. | 1.77e-05 | 3 | 85 | 2 | 30819023 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 27836549 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 19058785 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 31446433 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 8203495 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 15528190 | ||
| Pubmed | HIV-1 Tat-induced cerebrovascular toxicity is enhanced in mice with amyloid deposits. | 1.77e-05 | 3 | 85 | 2 | 21764480 | |
| Pubmed | Glial βII Spectrin Contributes to Paranode Formation and Maintenance. | 1.77e-05 | 3 | 85 | 2 | 29853631 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 23608773 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 25825495 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 26911348 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 20813982 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 25994790 | ||
| Pubmed | Nodal β spectrins are required to maintain Na+ channel clustering and axon integrity. | 1.77e-05 | 3 | 85 | 2 | 32052742 | |
| Pubmed | 1.82e-05 | 21 | 85 | 3 | 25708312 | ||
| Pubmed | 2.85e-05 | 144 | 85 | 5 | 35681168 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 21731499 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 12458206 | ||
| Pubmed | Gene structure of the murine 2'-5'-oligoadenylate synthetase family. | 3.53e-05 | 4 | 85 | 2 | 12222967 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 15947259 | ||
| Pubmed | Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas. | 3.53e-05 | 4 | 85 | 2 | 20043068 | |
| Pubmed | Glycosylation catalyzed by lysyl hydroxylase 3 is essential for basement membranes. | 3.53e-05 | 4 | 85 | 2 | 16467571 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 21849490 | ||
| Pubmed | Sec63 and Xbp1 regulate IRE1α activity and polycystic disease severity. | 3.53e-05 | 4 | 85 | 2 | 25844898 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 36096668 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 21050126 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 10521804 | ||
| Pubmed | Positive Regulation of Transcription by Human ZMYND8 through Its Association with P-TEFb Complex. | 3.53e-05 | 4 | 85 | 2 | 30134174 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 25865415 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 17446412 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 16412217 | ||
| Pubmed | Na,K-ATPase expression in the mouse cochlea is not dependent on the mineralocorticoid receptor. | 3.53e-05 | 4 | 85 | 2 | 11591489 | |
| Pubmed | PLODs are overexpressed in ovarian cancer and are associated with gap junctions via connexin 43. | 3.53e-05 | 4 | 85 | 2 | 33483598 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 20616063 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 19751721 | ||
| Pubmed | Agrin regulation of alpha3 sodium-potassium ATPase activity modulates cardiac myocyte contraction. | 3.53e-05 | 4 | 85 | 2 | 19376779 | |
| Pubmed | Altered GABA(A) receptor subunit expression and pharmacology in human Angelman syndrome cortex. | 3.53e-05 | 4 | 85 | 2 | 20692323 | |
| Pubmed | The Sec61 translocon limits IRE1α signaling during the unfolded protein response. | 3.53e-05 | 4 | 85 | 2 | 28504640 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 17234593 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 2887455 | ||
| Pubmed | Roles and functions of HIV-1 Tat protein in the CNS: an overview. | 3.95e-05 | 27 | 85 | 3 | 24359561 | |
| Pubmed | 4.04e-05 | 378 | 85 | 7 | 34315543 | ||
| Pubmed | 4.79e-05 | 81 | 85 | 4 | 22723691 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | STIM1 USP34 PLOD3 DPP9 TJP1 DHRS7 OAS3 CHD4 ACAD10 ATP1A1 SEC63 PLOD2 NEDD4 | 4.95e-05 | 1451 | 85 | 13 | 30550785 |
| Pubmed | 5.52e-05 | 84 | 85 | 4 | 34159380 | ||
| Pubmed | The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities. | 5.87e-05 | 5 | 85 | 2 | 21142819 | |
| Pubmed | Multiple genes encode the human Na+,K+-ATPase catalytic subunit. | 5.87e-05 | 5 | 85 | 2 | 3035563 | |
| Pubmed | Mechanism of blood-retinal barrier breakdown induced by HIV-1 (Review). | 5.87e-05 | 5 | 85 | 2 | 24660027 | |
| Pubmed | The clathrin adaptor complex AP-1 binds HIV-1 and MLV Gag and facilitates their budding. | 5.87e-05 | 5 | 85 | 2 | 17538020 | |
| Pubmed | Itch suppression in mice and dogs by modulation of spinal α2 and α3GABAA receptors. | 5.87e-05 | 5 | 85 | 2 | 30104684 | |
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 17275003 | ||
| Pubmed | Genomic structure of the mouse 2',5'-oligoadenylate synthetase gene family. | 5.87e-05 | 5 | 85 | 2 | 12396720 | |
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 21857898 | ||
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 20534982 | ||
| Pubmed | CHD4 Promotes Breast Cancer Progression as a Coactivator of Hypoxia-Inducible Factors. | 5.87e-05 | 5 | 85 | 2 | 32699137 | |
| Cytoband | Xq28 | 3.32e-04 | 176 | 85 | 4 | Xq28 | |
| Cytoband | 12q24.2 | 4.00e-04 | 16 | 85 | 2 | 12q24.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq28 | 6.80e-04 | 213 | 85 | 4 | chrXq28 | |
| Cytoband | 3q24 | 1.52e-03 | 31 | 85 | 2 | 3q24 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 3.75e-05 | 19 | 63 | 3 | 563 | |
| GeneFamily | ATPase Na+/K+ transporting subunits | 2.48e-04 | 7 | 63 | 2 | 1208 | |
| GeneFamily | CD molecules|DASH family | 2.48e-04 | 7 | 63 | 2 | 1205 | |
| GeneFamily | Myosins, class I | 3.30e-04 | 8 | 63 | 2 | 1097 | |
| GeneFamily | Dyneins, axonemal | 1.57e-03 | 17 | 63 | 2 | 536 | |
| Coexpression | GSE37534_GW1929_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP | 3.50e-06 | 198 | 84 | 7 | M8985 | |
| Coexpression | CROMER_TUMORIGENESIS_UP | 3.65e-05 | 58 | 84 | 4 | M178 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR | 3.91e-05 | 59 | 84 | 4 | M47989 | |
| Coexpression | GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN | 4.17e-05 | 197 | 84 | 6 | M3472 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_6_7WK_UP | 4.41e-05 | 199 | 84 | 6 | MM991 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_6_7WK_UP | 4.41e-05 | 199 | 84 | 6 | M2155 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDC_DN | 4.54e-05 | 200 | 84 | 6 | M3891 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma-osteoclast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.52e-06 | 188 | 84 | 6 | 762b52f21d2bc5409f86746a904c4358490be9c0 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NK|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.77e-06 | 193 | 84 | 6 | 1b29525c5936d1b779253b8c20f059fa091c6127 | |
| ToppCell | ASK440-Epithelial-Type_2|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.94e-06 | 196 | 84 | 6 | 754b4202b617165c6994a0b5a9b1e486dccdd44d | |
| ToppCell | P03-Hematopoietic-Immune-immune_cell_unspecified|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.31e-06 | 149 | 84 | 5 | 43d756f81d532b5c7f2306e6af9d072d496cbc8e | |
| ToppCell | P03-Hematopoietic-Immune|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.31e-06 | 149 | 84 | 5 | 1c5a2572741c47246d455c865e8e1677c9f49598 | |
| ToppCell | facs-Aorta-Heart-18m-Mesenchymal-fibrocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-05 | 156 | 84 | 5 | 5b56217336771baf57d791efcb4e206c6aea83b1 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.16e-05 | 156 | 84 | 5 | abea3c183d32062b009a79a2bdf861021989c7ef | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.53e-05 | 165 | 84 | 5 | 436ce4bc75e1ba4351c439ccad19f84ad5bcb92f | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.53e-05 | 165 | 84 | 5 | 242bdb7654f415391fb8e9bdc06412c7eee9c97e | |
| ToppCell | droplet-Bladder-BLADDER-1m-Hematologic-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 166 | 84 | 5 | 8e5a262dc4f04c5fc75b9a7a907832a0d7877df0 | |
| ToppCell | droplet-Bladder-nan-3m-Hematologic-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 166 | 84 | 5 | e01c720de6d4ca144c55378e023e718a64bf32f6 | |
| ToppCell | facs-Trachea-nan-24m-Myeloid-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 169 | 84 | 5 | 87e95804b3b19c245cea6293d72b64351293b0e8 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Hematologic-hematopoietic_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 173 | 84 | 5 | 7456a417c5c1d4ba25f9489065aae322421308a6 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Hematologic-hematopoietic_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 173 | 84 | 5 | 35586a9e5f15b41609b6224e33eb3aa3cb7e03b7 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Hematologic|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 173 | 84 | 5 | cd635751f999e12b14c0accfa1c4c1fd3c1d4540 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.97e-05 | 174 | 84 | 5 | 7d4b860e05b5931f6f9d757a68f75ff35597a47a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.08e-05 | 176 | 84 | 5 | ed421d8525108d2f585265d2cf777f07b29f44f0 | |
| ToppCell | 15-Airway-Immune-Hematopoietic,_Natural_Killer_Cell|Airway / Age, Tissue, Lineage and Cell class | 2.20e-05 | 178 | 84 | 5 | 0003c3f2561b7a1fd86772bcba59883ba1f17cd2 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.57e-05 | 184 | 84 | 5 | 087666ba949b129c53d7ace40f9e543e3875a7de | |
| ToppCell | metastatic_Brain-Endothelial_cells-Stalk-like_ECs|metastatic_Brain / Location, Cell class and cell subclass | 2.64e-05 | 185 | 84 | 5 | ad52970e88e8947ef256095bd4b40229b912d58a | |
| ToppCell | IPF-Epithelial-ATII|IPF / Disease state, Lineage and Cell class | 2.64e-05 | 185 | 84 | 5 | 563b4e6d92bb5d77a3829556116a8e99aebac615 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_macrophage-stroma-osteoclast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.64e-05 | 185 | 84 | 5 | 5ed49b6d8214c6119355a6d3ee4e25d40bcc0c53 | |
| ToppCell | IPF-Epithelial-ATII|World / Disease state, Lineage and Cell class | 2.71e-05 | 186 | 84 | 5 | 6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage-stroma-osteoclast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.71e-05 | 186 | 84 | 5 | c9dfcf7bba7e5ef97ad5d9b7084fba932c91ab68 | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.32e-05 | 194 | 84 | 5 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-05 | 195 | 84 | 5 | 938b31dbf1674ee6fd0123bc88391ddcaf151217 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.40e-05 | 195 | 84 | 5 | 07a3ef6b0f1201fe2bcb9ea426b8f7a69beb4904 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-Trm_Th1/Th17|lymph-node_spleen / Manually curated celltypes from each tissue | 3.40e-05 | 195 | 84 | 5 | c60982804a74dbe6607c021799ca74af2204aba8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-05 | 195 | 84 | 5 | d39e9e6544f49e677ebe528c6fe60b99a3630e30 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.40e-05 | 195 | 84 | 5 | b65511770ed67f7447847e2187555b362988af45 | |
| ToppCell | Children_(3_yrs)-Endothelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.40e-05 | 195 | 84 | 5 | 094cf6591daa5ffad36e44122b6f524a3a34c2fd | |
| ToppCell | ASK454-Endothelial-Endothelium|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.48e-05 | 196 | 84 | 5 | 2b777a2026b56839112fd179f2db482c49f4594a | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.48e-05 | 196 | 84 | 5 | a7cbe66ebd8931ef2b8ff26a42afce0ad1c48f17 | |
| ToppCell | COPD-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 3.48e-05 | 196 | 84 | 5 | c9bdd505c3ab380ed7b272aa518df31a0a706a06 | |
| ToppCell | ASK440-Epithelial-Type_2|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.57e-05 | 197 | 84 | 5 | 08d5bbeb77a4152af1c783bc958afcae24667767 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.57e-05 | 197 | 84 | 5 | 7a1a3839b2c965136663241b0d4e96c64cfb656a | |
| ToppCell | normal_Lung-Endothelial_cells-Stalk-like_ECs|normal_Lung / Location, Cell class and cell subclass | 3.65e-05 | 198 | 84 | 5 | 2a251d13c2488d15ca9b11e643c1d17d428b6ef0 | |
| ToppCell | AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 3.65e-05 | 198 | 84 | 5 | 893036558a9ad86b57f9e735df35812e9d18739e | |
| ToppCell | ILEUM-non-inflamed-(7)_ACKR1+_endothelial_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.65e-05 | 198 | 84 | 5 | f8a6a75c9f2fbe32a22b14b6a029411c73c09f68 | |
| ToppCell | Biopsy_Other_PF-Epithelial-AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.74e-05 | 199 | 84 | 5 | 9a65acfe9bf500db72142469cf17bf0973540001 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD4-CD4_TRM/EMRA|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.74e-05 | 199 | 84 | 5 | 5a29db2610ba06a2248325a16cad755d20debf2c | |
| ToppCell | Biopsy_IPF-Epithelial-Transitional_AT2|Biopsy_IPF / Sample group, Lineage and Cell type | 3.74e-05 | 199 | 84 | 5 | 83ff8b7e472d1212324c05cc719b746d19e5e23b | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.74e-05 | 199 | 84 | 5 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 200 | 84 | 5 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 200 | 84 | 5 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.83e-05 | 200 | 84 | 5 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 200 | 84 | 5 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 200 | 84 | 5 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.83e-05 | 200 | 84 | 5 | acc771a902cf2f060c3eb9aedb72a256f5778a6c | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-AT2-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.83e-05 | 200 | 84 | 5 | ceb613ac6cdf0e3e6bb3f04d89034e18a524cefb | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 200 | 84 | 5 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 200 | 84 | 5 | abf4ba5fcb54cdeada0da1a8b956a30aa47679e4 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 200 | 84 | 5 | 3585484c7e24e941708bee471ca607d8ccee74e6 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.83e-05 | 200 | 84 | 5 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.83e-05 | 200 | 84 | 5 | eb44d1f80ecaac3a022cd04ab16dc36151e45488 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Interneuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 8.13e-05 | 121 | 84 | 4 | b2d571f571133c281d72584fe925cebbd2317829 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Granulocytic-Neutrophil|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.59e-04 | 144 | 84 | 4 | 1efa434e577d1f87e02df01667782f414d63bd60 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.59e-04 | 144 | 84 | 4 | c0c5f254a960ba5e5f1354599d54e77360e6c2ac | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.63e-04 | 145 | 84 | 4 | ab0e254a8d01021619853a6c175f620ccef217d8 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Neutrophil|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.63e-04 | 145 | 84 | 4 | 2beb4ea3838796c580076ab7769de877a3a0552c | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Sema3c_(Deep_layer_pyramidal_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.71e-04 | 57 | 84 | 3 | 8b0990dad1dac9ab898db47a10e652c753012f4b | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Sema3c_(Deep_layer_pyramidal_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.71e-04 | 57 | 84 | 3 | a31e226e26fd621df88a855ca899eea046fe0b71 | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.72e-04 | 147 | 84 | 4 | a21b63d0d3aec9ffadf3fac833a0a24da58a95bf | |
| ToppCell | facs-Skin-nan-18m-Myeloid-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 149 | 84 | 4 | 23a1b95c12f2e3708dc003e13fab423e89821f11 | |
| ToppCell | facs-Skin-nan-18m-Myeloid-macrophage|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 149 | 84 | 4 | c53a3226adc8fd0eaaa842b6a96442287580cbe0 | |
| ToppCell | facs-Skin-nan-18m-Myeloid|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 149 | 84 | 4 | bb18a18b891af85849b9658d774053f839c9a8e1 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 151 | 84 | 4 | 3105b8c0c401faa92e1ab8223d435b21ed45c5b7 | |
| ToppCell | mild_COVID-19_(asymptomatic)-MAIT|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 2.01e-04 | 153 | 84 | 4 | 26852f3d8f80e102e24bcb90e24aac26fdc9a32c | |
| ToppCell | CV-Healthy-3|Healthy / Virus stimulation, Condition and Cluster | 2.06e-04 | 154 | 84 | 4 | 26bf81a86700db7e65c2384ffe94ed4253ea4047 | |
| ToppCell | AT1-AT2_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 2.11e-04 | 155 | 84 | 4 | 010e45ef4b505bf419ea41e4d1619521d1c78319 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT2_Precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.11e-04 | 155 | 84 | 4 | 9cad73d0b8ead289e1073d1a2e00bbeb1228308c | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-04 | 157 | 84 | 4 | d2cb261a9ee2c90e2e0fc656bd6413fbccb465fc | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-04 | 157 | 84 | 4 | 350069e4d2dbddc82e813e2a2cc43032daa23605 | |
| ToppCell | severe_COVID-19-MAIT|severe_COVID-19 / disease group, cell group and cell class (v2) | 2.22e-04 | 157 | 84 | 4 | 175f637e9707836bd63b5c2ccc9d4eb601c05b9e | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 158 | 84 | 4 | b0508a600994090c6aafd8d779437190a33ad821 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 158 | 84 | 4 | 2a222301474c4dfd9a776e197c10f4c1cacceb62 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 2.27e-04 | 158 | 84 | 4 | ab05f6d7968ccd6d3826cd71b763dbedc83822c3 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1-41|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.27e-04 | 158 | 84 | 4 | 6d2709b387945c015faa223c20d22b52a4082140 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 158 | 84 | 4 | a816cc095452308d06f87b77467e2a8c6361fd2a | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 158 | 84 | 4 | ff9878fd768f22bf2ee4805bac2ba01cb3cb804a | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-interstitial_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.27e-04 | 158 | 84 | 4 | 9a6d9b541446a6aa9f8ed040b330dbb5c6447076 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l12|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.27e-04 | 158 | 84 | 4 | 2438713d2a7e32c647ab3384237ed614f4ec8fec | |
| ToppCell | facs-Lung-nan-3m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-04 | 159 | 84 | 4 | 836c4b5f9a714ffb5a449087ebefdbb37dd3a2a9 | |
| ToppCell | 18-Airway-Epithelial-Bud_tip_progenitor|Airway / Age, Tissue, Lineage and Cell class | 2.33e-04 | 159 | 84 | 4 | e715cadff8e7d5ebe4c2198dbdfd3ca41ecb8a6a | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.33e-04 | 159 | 84 | 4 | af137688e06a97ff97bb7def54f0dd164d155b11 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-04 | 159 | 84 | 4 | a6742ba2216427409173aec4e05a537d7fde226c | |
| ToppCell | facs-MAT-Fat-18m-Myeloid-myeloid_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 160 | 84 | 4 | bd5fa7959bfe81011b8d798535b73ea1eee008b3 | |
| ToppCell | CV-Healthy-3|CV / Virus stimulation, Condition and Cluster | 2.44e-04 | 161 | 84 | 4 | fd4a79385ea967b9900dc76a3add813b894a3a28 | |
| ToppCell | facs-MAT-Fat-24m-Myeloid-myeloid_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-04 | 161 | 84 | 4 | 65888250b8c1da6a8f9b5376e086a3769a1cbbd8 | |
| ToppCell | facs-Thymus-Epithelium-3m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-04 | 162 | 84 | 4 | 3dc39db0d5f6f3d7bcc312a6bce7aaeb914138d1 | |
| ToppCell | facs-Thymus-Epithelium-3m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-04 | 162 | 84 | 4 | 0a7138266054ea5954649c8b61ef93905d56b068 | |
| ToppCell | facs-Thymus-Epithelium-3m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-04 | 162 | 84 | 4 | 25323785dd33337bcefd05958a4a1a208a9ceb04 | |
| ToppCell | facs-MAT-Fat-3m-Myeloid-myeloid_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-04 | 163 | 84 | 4 | 5fc836444bc156c8248abee001b0ecbe43f980c9 | |
| ToppCell | droplet-Fat-Mat-18m-Myeloid-monocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-04 | 164 | 84 | 4 | a27b9b3380f29bb17c9f787423f2591f2b9cf33e | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.62e-04 | 164 | 84 | 4 | d6f71d804bb65301c02ea4e6673e20688b5fcd5b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.62e-04 | 164 | 84 | 4 | 8f3255d7f67890389a768453492243ea982eb38a | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-intermediate_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-04 | 165 | 84 | 4 | e32697321cef424c2ad4e11ee9da3e510d5ce505 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.68e-04 | 165 | 84 | 4 | fee7f2f8d0e25c0d067adc73f8913721bd709a3e | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Intermediate_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-04 | 165 | 84 | 4 | 0fbdd043e11aa8dbff4cd3a4da1b2feb49878a09 | |
| ToppCell | facs-MAT-Fat-18m-Myeloid|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-04 | 166 | 84 | 4 | 9116be2805c34881debb999d8417e43832fcf2f2 | |
| Drug | AGEPC | 7.31e-06 | 356 | 85 | 9 | CID000461545 | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; PC3; HT_HG-U133A | 8.81e-06 | 196 | 85 | 7 | 4100_DN | |
| Drug | Cefotiam hydrochloride; Down 200; 7.2uM; MCF7; HT_HG-U133A | 9.11e-06 | 197 | 85 | 7 | 3319_DN | |
| Drug | C5-substituted pyrrolidine 31 | 1.38e-05 | 2 | 85 | 2 | CID010339570 | |
| Drug | neostigmine | 1.87e-05 | 87 | 85 | 5 | CID000004456 | |
| Drug | zileuton | 2.85e-05 | 47 | 85 | 4 | ctd:C063449 | |
| Drug | dihydroxyaflavinine | 3.29e-05 | 17 | 85 | 3 | CID000156857 | |
| Drug | Losartan | 3.60e-05 | 165 | 85 | 6 | ctd:D019808 | |
| Drug | coproporphyrin I | 3.93e-05 | 18 | 85 | 3 | CID000068271 | |
| Drug | SureCN3749646 | 4.12e-05 | 3 | 85 | 2 | CID011530920 | |
| Drug | SureCN3745540 | 4.12e-05 | 3 | 85 | 2 | CID011974437 | |
| Drug | SureCN3749947 | 4.12e-05 | 3 | 85 | 2 | CID011974435 | |
| Drug | ABT-279 | 4.12e-05 | 3 | 85 | 2 | CID016049769 | |
| Drug | Cyanopyrrolidine 39 | 4.12e-05 | 3 | 85 | 2 | CID011117606 | |
| Drug | Cyanopyrrolidine 38 | 4.12e-05 | 3 | 85 | 2 | CID010932707 | |
| Drug | SureCN3748611 | 4.12e-05 | 3 | 85 | 2 | CID011974325 | |
| Drug | Diprolyl-alanine | 4.12e-05 | 3 | 85 | 2 | CID000193559 | |
| Drug | sulfobromophthalein | 4.23e-05 | 103 | 85 | 5 | CID000005345 | |
| Drug | triazolam | 4.96e-05 | 54 | 85 | 4 | CID000005556 | |
| Drug | prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A | 6.42e-05 | 183 | 85 | 6 | 6547_UP | |
| Drug | Monobenzone [103-16-2]; Down 200; 20uM; MCF7; HT_HG-U133A | 7.02e-05 | 186 | 85 | 6 | 3391_DN | |
| Drug | etizolam | 7.35e-05 | 22 | 85 | 3 | CID000003307 | |
| Drug | phenobarbital quinidine | 7.35e-05 | 22 | 85 | 3 | ctd:C033457 | |
| Drug | AC1L19X5 | 7.35e-05 | 22 | 85 | 3 | CID000000741 | |
| Drug | parthenolide | 7.52e-05 | 60 | 85 | 4 | ctd:C002669 | |
| Drug | 5 beta-pregnanediol | 7.52e-05 | 60 | 85 | 4 | CID000012547 | |
| Drug | glycylproline 4-nitroanilide | 8.22e-05 | 4 | 85 | 2 | ctd:C042892 | |
| Drug | Flumazenil | 8.22e-05 | 4 | 85 | 2 | DB01205 | |
| Drug | etizolam | 8.22e-05 | 4 | 85 | 2 | ctd:C044610 | |
| Drug | ApApA(Sp)A | 8.22e-05 | 4 | 85 | 2 | CID000501019 | |
| Drug | ApA(Sp)A | 8.22e-05 | 4 | 85 | 2 | CID000501015 | |
| Drug | ApA(Sp)ApA | 8.22e-05 | 4 | 85 | 2 | CID000501017 | |
| Drug | A(Sp)ApA | 8.22e-05 | 4 | 85 | 2 | CID000501013 | |
| Drug | adenosine N'-oxide | 8.22e-05 | 4 | 85 | 2 | CID000459896 | |
| Drug | poly(I,8-azidoI).poly(C | 8.22e-05 | 4 | 85 | 2 | CID003081572 | |
| Drug | 15(S)-15-methyl Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A | 8.37e-05 | 192 | 85 | 6 | 7526_UP | |
| Drug | BB-882 | 8.43e-05 | 23 | 85 | 3 | CID000060856 | |
| Drug | Sparteine (-) [90-39-1]; Down 200; 17uM; MCF7; HT_HG-U133A | 8.86e-05 | 194 | 85 | 6 | 4391_DN | |
| Drug | Ethambutol dihydrochloride [1070-11-7]; Down 200; 14.4uM; PC3; HT_HG-U133A | 8.86e-05 | 194 | 85 | 6 | 4001_DN | |
| Drug | Ramipril [87333-19-5]; Up 200; 9.6uM; PC3; HT_HG-U133A | 9.11e-05 | 195 | 85 | 6 | 7144_UP | |
| Drug | Etofenamate [30544-47-9]; Down 200; 10.8uM; HL60; HT_HG-U133A | 9.37e-05 | 196 | 85 | 6 | 2907_DN | |
| Drug | Midecamycin [35457-80-8]; Up 200; 5uM; MCF7; HT_HG-U133A | 9.37e-05 | 196 | 85 | 6 | 5345_UP | |
| Drug | Delcorine; Down 200; 8.4uM; MCF7; HT_HG-U133A | 9.37e-05 | 196 | 85 | 6 | 3613_DN | |
| Drug | methohexital | 9.60e-05 | 24 | 85 | 3 | CID000009034 | |
| Drug | Metformin hydrochloride [1115-70-4]; Down 200; 24.2uM; PC3; HT_HG-U133A | 9.91e-05 | 198 | 85 | 6 | 1816_DN | |
| Drug | Famotidine [76824-35-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 9.91e-05 | 198 | 85 | 6 | 1529_UP | |
| Drug | Hippeastrine hydrobromide [22352-41-6]; Up 200; 10uM; PC3; HT_HG-U133A | 9.91e-05 | 198 | 85 | 6 | 7381_UP | |
| Drug | Bergenin monohydrate [477-90-7]; Down 200; 11.6uM; PC3; HT_HG-U133A | 1.02e-04 | 199 | 85 | 6 | 5870_DN | |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HT_HG-U133A | 1.02e-04 | 199 | 85 | 6 | 5575_DN | |
| Drug | Clebopride maleate [84370-95-6]; Down 200; 8.2uM; PC3; HT_HG-U133A | 1.02e-04 | 199 | 85 | 6 | 6311_DN | |
| Drug | Eszopiclone | 1.37e-04 | 5 | 85 | 2 | DB00402 | |
| Drug | prodipine | 1.37e-04 | 5 | 85 | 2 | CID000065775 | |
| Drug | 22,23-dihydrobufalin | 1.37e-04 | 5 | 85 | 2 | CID000195392 | |
| Drug | Zopiclone | 1.37e-04 | 5 | 85 | 2 | DB01198 | |
| Drug | thevetin A | 1.37e-04 | 5 | 85 | 2 | CID000441873 | |
| Drug | arginyl(PMC)-pyrrolidine-2-nitrile | 1.37e-04 | 5 | 85 | 2 | CID000487437 | |
| Drug | dehydro-histidinohydroxymerodesmosine | 1.37e-04 | 5 | 85 | 2 | CID003037599 | |
| Drug | 3-acetylstrophanthin | 1.37e-04 | 5 | 85 | 2 | CID003082282 | |
| Drug | alanylproline-4-nitroanilide | 1.37e-04 | 5 | 85 | 2 | ctd:C083013 | |
| Drug | BAPN | 1.45e-04 | 71 | 85 | 4 | CID000001647 | |
| Drug | Texas Red | 1.54e-04 | 28 | 85 | 3 | CID000452705 | |
| Drug | stilbene oxide | 1.71e-04 | 74 | 85 | 4 | CID000028649 | |
| Drug | NSC9567 | 1.87e-04 | 141 | 85 | 5 | CID000003001 | |
| Drug | 3-isothujone | 1.90e-04 | 30 | 85 | 3 | CID000011027 | |
| Drug | cathepsin C substrate | 2.05e-04 | 6 | 85 | 2 | CID003508173 | |
| Drug | Meprobamate | 2.05e-04 | 6 | 85 | 2 | DB00371 | |
| Drug | Flunitrazepam | 2.05e-04 | 6 | 85 | 2 | DB01544 | |
| Drug | pyridinium formate | 2.05e-04 | 6 | 85 | 2 | CID013326228 | |
| Drug | II 19 | 2.05e-04 | 6 | 85 | 2 | CID000040321 | |
| Drug | Protease Inhibitors | 2.05e-04 | 6 | 85 | 2 | ctd:D011480 | |
| Drug | NVP-DPP728 | 2.05e-04 | 6 | 85 | 2 | CID009796290 | |
| Drug | MK-251 | 2.05e-04 | 6 | 85 | 2 | CID000176160 | |
| Drug | MX220 | 2.05e-04 | 6 | 85 | 2 | CID000514000 | |
| Drug | ETH157 | 2.05e-04 | 6 | 85 | 2 | CID000563154 | |
| Drug | CGS 8216 | 2.53e-04 | 33 | 85 | 3 | CID000104916 | |
| Drug | AC1L2FYN | 2.53e-04 | 33 | 85 | 3 | CID000071333 | |
| Drug | clonazepam | 2.53e-04 | 82 | 85 | 4 | CID000002802 | |
| Drug | Quazepam | 2.86e-04 | 7 | 85 | 2 | DB01589 | |
| Drug | Epostatin | 2.86e-04 | 7 | 85 | 2 | CID006449105 | |
| Drug | o-Py | 2.86e-04 | 7 | 85 | 2 | CID009942336 | |
| Drug | dihydrodigitoxigenin | 2.86e-04 | 7 | 85 | 2 | CID000107549 | |
| Drug | flurazepam | 3.01e-04 | 35 | 85 | 3 | CID000003393 | |
| Drug | sodium; lithium | 3.28e-04 | 36 | 85 | 3 | CID012725854 | |
| Drug | AC1LCF1F | 3.45e-04 | 161 | 85 | 5 | CID000627275 | |
| Drug | secobarbital | 3.56e-04 | 37 | 85 | 3 | CID000005193 | |
| Drug | Adinazolam | 3.80e-04 | 8 | 85 | 2 | DB00546 | |
| Drug | CID6451162 | 3.80e-04 | 8 | 85 | 2 | CID006451162 | |
| Drug | HHMD | 3.80e-04 | 8 | 85 | 2 | CID000171068 | |
| Drug | Fludiazepam | 3.80e-04 | 8 | 85 | 2 | DB01567 | |
| Drug | Clotiazepam | 3.80e-04 | 8 | 85 | 2 | DB01559 | |
| Drug | Cinolazepam | 3.80e-04 | 8 | 85 | 2 | DB01594 | |
| Drug | Prazepam | 3.80e-04 | 8 | 85 | 2 | DB01588 | |
| Drug | Estazolam | 3.80e-04 | 8 | 85 | 2 | DB01215 | |
| Drug | V-V2 | 3.80e-04 | 8 | 85 | 2 | CID000198267 | |
| Drug | Halazepam | 3.80e-04 | 8 | 85 | 2 | DB00801 | |
| Drug | coumalic acid | 3.80e-04 | 8 | 85 | 2 | CID000068141 | |
| Drug | hydroxyallysine | 3.80e-04 | 8 | 85 | 2 | CID000153008 | |
| Drug | P32/98 | 3.80e-04 | 8 | 85 | 2 | CID006918464 | |
| Drug | imidazolelactate | 3.80e-04 | 8 | 85 | 2 | CID000000793 | |
| Drug | DMCM | 3.85e-04 | 38 | 85 | 3 | CID000104999 | |
| Disease | newborn respiratory distress syndrome (implicated_via_orthology) | 2.23e-05 | 3 | 81 | 2 | DOID:12716 (implicated_via_orthology) | |
| Disease | hyperglycemia (biomarker_via_orthology) | 2.56e-05 | 21 | 81 | 3 | DOID:4195 (biomarker_via_orthology) | |
| Disease | Bipolar Disorder | 5.04e-05 | 477 | 81 | 8 | C0005586 | |
| Disease | bipolar disorder (is_implicated_in) | 6.92e-05 | 29 | 81 | 3 | DOID:3312 (is_implicated_in) | |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 1.55e-04 | 7 | 81 | 2 | DOID:0060178 (implicated_via_orthology) | |
| Disease | neutropenia (implicated_via_orthology) | 1.55e-04 | 7 | 81 | 2 | DOID:1227 (implicated_via_orthology) | |
| Disease | bilirubin metabolic disorder (biomarker_via_orthology) | 1.55e-04 | 7 | 81 | 2 | DOID:2741 (biomarker_via_orthology) | |
| Disease | coronary artery disease (is_implicated_in) | 1.69e-04 | 100 | 81 | 4 | DOID:3393 (is_implicated_in) | |
| Disease | Bone neoplasms | 2.06e-04 | 8 | 81 | 2 | C0005967 | |
| Disease | Malignant Bone Neoplasm | 2.06e-04 | 8 | 81 | 2 | C0279530 | |
| Disease | intracranial aneurysm (is_implicated_in) | 4.83e-04 | 12 | 81 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | dodecanedioate measurement | 4.83e-04 | 12 | 81 | 2 | EFO_0021054 | |
| Disease | nervous system disease (implicated_via_orthology) | 4.83e-04 | 12 | 81 | 2 | DOID:863 (implicated_via_orthology) | |
| Disease | Malformations of Cortical Development | 6.63e-04 | 14 | 81 | 2 | C1955869 | |
| Disease | Cortical Dysplasia | 6.63e-04 | 14 | 81 | 2 | C0431380 | |
| Disease | Sclerocystic Ovaries | 6.76e-04 | 144 | 81 | 4 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 6.76e-04 | 144 | 81 | 4 | C0032460 | |
| Disease | Schizophrenia | 7.03e-04 | 883 | 81 | 9 | C0036341 | |
| Disease | brain edema (biomarker_via_orthology) | 7.64e-04 | 15 | 81 | 2 | DOID:4724 (biomarker_via_orthology) | |
| Disease | Keloid | 9.85e-04 | 17 | 81 | 2 | EFO_0004212 | |
| Disease | multiple sclerosis (is_implicated_in) | 1.08e-03 | 73 | 81 | 3 | DOID:2377 (is_implicated_in) | |
| Disease | DiGeorge syndrome (implicated_via_orthology) | 1.23e-03 | 19 | 81 | 2 | DOID:11198 (implicated_via_orthology) | |
| Disease | COVID-19, osteoarthritis | 1.37e-03 | 20 | 81 | 2 | MONDO_0005178, MONDO_0100096 | |
| Disease | urticaria | 1.37e-03 | 20 | 81 | 2 | EFO_0005531 | |
| Disease | hypothyroidism (biomarker_via_orthology) | 1.41e-03 | 80 | 81 | 3 | DOID:1459 (biomarker_via_orthology) | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 1.41e-03 | 80 | 81 | 3 | DOID:6432 (biomarker_via_orthology) | |
| Disease | kidney disease (biomarker_via_orthology) | 1.51e-03 | 21 | 81 | 2 | DOID:557 (biomarker_via_orthology) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.07e-03 | 195 | 81 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | Myocardial Infarction | 2.30e-03 | 95 | 81 | 3 | C0027051 | |
| Disease | adult respiratory distress syndrome (is_marker_for) | 2.32e-03 | 26 | 81 | 2 | DOID:11394 (is_marker_for) | |
| Disease | Kallmann Syndrome | 2.32e-03 | 26 | 81 | 2 | C0162809 | |
| Disease | acute kidney failure (implicated_via_orthology) | 2.50e-03 | 27 | 81 | 2 | DOID:3021 (implicated_via_orthology) | |
| Disease | Cerebral Hemorrhage | 2.69e-03 | 28 | 81 | 2 | C2937358 | |
| Disease | obesity (is_marker_for) | 2.74e-03 | 101 | 81 | 3 | DOID:9970 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YVWLETQGTVIYNPR | 316 | Q99814 | |
| RIENLELVPVEYQWY | 401 | O75366 | |
| PRDNQLYVWNNYFVV | 376 | O94910 | |
| IENPYWSVRALVQQY | 191 | Q155Q3 | |
| QLLNNYPVYITSKQW | 386 | Q6ZU67 | |
| LPWVRYITQNGDYQL | 406 | Q9BXS5 | |
| NQQWLVYDQQREVYV | 181 | Q53EZ4 | |
| DYIPRQVRTWVKQYR | 416 | Q6JQN1 | |
| VIPWVIVRYLYENTQ | 271 | P48546 | |
| ISEQPFLLVTYLWQY | 286 | Q9Y394 | |
| SNYNFEIPKTIWRIQ | 56 | Q9BZG8 | |
| LNPAVYRNVEYEIWL | 251 | Q01804 | |
| LWVYVYVDPNNVLDA | 551 | O15438 | |
| KRVIATYQNIAVYEW | 281 | Q9NRD9 | |
| YSYVLQWTQREPDAV | 656 | Q8NFP4 | |
| KRVGVWNVPYISQAY | 451 | O60568 | |
| QVGYEDQWLQLLRTY | 616 | O60568 | |
| SIEPVIYVVQRRWNY | 211 | P23352 | |
| ITYWIQNYSEDLPRA | 121 | P14780 | |
| YAQQVQAPVELYSDW | 461 | Q6TGC4 | |
| LVPYVVNVSWATQYC | 351 | Q12891 | |
| QEWVQENYLEYRQAP | 251 | P43361 | |
| QNWVQEKYLVYRQVP | 361 | P43364 | |
| YIYLVIQWRFVNRIQ | 1151 | P46934 | |
| PQYSWKRYNILNQEQ | 171 | Q99795 | |
| ETRQENYWLIQYQRL | 541 | Q6UWE0 | |
| VQREVNSYLVQVYWP | 261 | Q9UN88 | |
| NSYLVQVYWPTVLTT | 266 | Q9UN88 | |
| EILLSFPQNYYIQWL | 86 | Q8WVP7 | |
| SYGQQWTYEQRKIVE | 901 | P05023 | |
| EVLSWVLQYYQVPEK | 101 | Q7Z412 | |
| VVNINLRNKPEWYYT | 51 | Q9H4Y5 | |
| VYPVHVQLYEAWKQV | 436 | P52848 | |
| WYISNTLIQIIPTYI | 126 | Q9BYS8 | |
| SPSYYWIGIRKVNNV | 66 | P16581 | |
| WYRYRPLVAELVVQN | 181 | Q96KN4 | |
| YVWNNDIYVKIEPNL | 166 | P27487 | |
| NLVYWATYVNRESAI | 471 | P34903 | |
| NLVYWATYLNREPVI | 441 | P31644 | |
| KYWDQRYTIVQQQIP | 426 | Q9BSJ2 | |
| GYAPYVNRIVQQWNL | 171 | O00469 | |
| WYQQYVKARSPRANL | 216 | Q15646 | |
| NNYPNNWECIYRITV | 1066 | O60494 | |
| ENKTQPQVAYQYWPL | 201 | P87889 | |
| IPPLNNLQWYIYEKQ | 91 | Q86XP6 | |
| VIYYQVKQPRWFETV | 481 | Q14185 | |
| LRYYWVAKDVQVQII | 1371 | Q8TD57 | |
| VLWIQNYASPVVAFY | 216 | O75460 | |
| NYASPVVAFYVWQRE | 221 | O75460 | |
| YWKSPRVPSEVQQRY | 216 | A8MYV0 | |
| NVQPYVVYEEVTNVW | 406 | Q86TI2 | |
| YVNPVIKWLSEEQRY | 1266 | P01031 | |
| RSWLINYIQEILRNY | 2226 | Q8WXX0 | |
| VKQYAVQSQLPVYEW | 96 | Q96DP5 | |
| YQYQVVLVEPKTAWR | 141 | P09543 | |
| SNVSYFVEWIKRQIY | 1021 | Q9Y5Q5 | |
| YIWQVIDQYSIPQVS | 311 | Q8NFW1 | |
| SYGQQWTYEQRKVVE | 891 | P13637 | |
| PYQVAWSIRETLRYQ | 341 | Q53TQ3 | |
| NTYITWIDKYQAQLV | 1736 | Q14204 | |
| YQQDYTVWVLPLIIV | 561 | Q8WWI5 | |
| YTYPQGTWQKVIQVV | 111 | Q15762 | |
| QPNRYTNRVVTLWYR | 181 | P50750 | |
| YARWQDIQNDPRYAI | 1746 | Q14839 | |
| LESRIQEWYEFQIPY | 121 | O76013 | |
| LVTQYRQLCIYWTIN | 1001 | Q9Y6K5 | |
| YTGTLPLWVIYIRNQ | 91 | Q9UNW8 | |
| QDTLYWNNYKTPVQI | 21 | Q8TED0 | |
| KIFYYIPWIENVIQN | 226 | Q8IYP2 | |
| WNLYIVNTISPVQLY | 486 | Q969F9 | |
| YISQQEYKPRWSQII | 241 | Q9UL63 | |
| FLITLPLWIVYYQNQ | 66 | P25105 | |
| VYTRVSQYIEWLQKL | 436 | P08709 | |
| ITVQYYLWPQGLVRE | 191 | A6NNN8 | |
| LTAIYQQLNRWKYIQ | 321 | P29371 | |
| EVVQWLITYVELPQY | 136 | Q13586 | |
| VNQPWYIHALYTVIR | 201 | Q5SYC1 | |
| ITPEWRKQYIQYEAF | 11 | Q9UBH6 | |
| TYYLWPRDQNAEQIR | 31 | Q9UGP8 | |
| CYNYIRVLVPWDSQT | 121 | Q9H3T2 | |
| VALEQQYWLYQLSRQ | 1721 | Q9H254 | |
| QYWLYQLSRQVSELE | 1726 | Q9H254 | |
| YWAGKTYVIQRQSVL | 761 | P08922 | |
| NAVDRLNYAQWYPIV | 711 | Q07157 | |
| YILQRIWEVIEYNPS | 2626 | Q70CQ2 | |
| VLQSIPYQPKVYDIW | 186 | Q96PF2 | |
| YNTVTRQWLYLKENT | 421 | Q9P2K6 | |
| QIVIAAWYRRYAQQK | 731 | O43795 | |
| YVQEGIRWTPIQYFN | 426 | O00160 |